ArticleBiologics : targets & therapy2018

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results.

Yuji Nozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.